搜狐7 天
FDA 扩大批准用于儿科适应症的肿瘤和自身免疫药
美国食品药品管理局 (FDA) 扩大了 Jylamvo（甲氨蝶呤）的批准范围，将其作为联合化疗维持方案的一部分，用于治疗儿童急性淋巴细胞白血病 (ALL ...
Monthly Prescribing Reference1 个月
Jylamvo Approval Expanded to Include Pediatric ALL, pJIA
Credit: Shorla Oncology. Jylamvo is an oral solution formulation of methotrexate. The orange-flavored oral solution is stable at room temperature for 90 days. The Food and Drug Administration (FDA ...
Cure Today1 个月
FDA Expands Approval for Jylamvo to Children With Acute Lymphoblastic Leukemia
Jylamvo is now approved for pediatric acute lymphoblastic leukemia and juvenile idiopathic arthritis, offering a liquid methotrexate formulation. The formulation is stable at room temperature for 90 ...